Metastasis to the penis from RCC or any other primary cancer site is unusual; when it does occur, it often involves multiple organs. A 75-year-old man presented with penile pain and swelling. Three months earlier, he had open radical nephrectomy with thrombectomy and was diagnosed with clear-cell RCC with tumor thrombosis in the IVC. The follow-up imaging indicated metastasis in the penis, prompting a total penectomy due to worsening pain. The excised mass displayed features consistent with metastatic RCC. This case underscores the need to consider rare metastatic sites, such as metastasis of RCC to the penis, in RCC patients.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10990721 | PMC |
| http://dx.doi.org/10.1016/j.eucr.2024.102724 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Prospective validation of clino-radio-pathological risk scoring system (CRiSS) for prediction of inguinal lymph-nodes metastasis in squamous cell carcinoma of penis.
Urol Oncol
December 2024
Department of Surgical Oncology, The Gujarat Cancer Research Institute, Ahmedabad, Gujarat, India.
Objective: To prospectively validate the diagnostic performance of Clino-radio-pathological Risk Scoring System (CRiSS) for prediction of inguinal lymph-node metastasis (ILNM) in squamous cell carcinoma of penis.
Materials And Methods: A prospective observational study of all patients with SCC penis was conducted between January 1, 2021, and December 31, 2023, at our institute. Data regarding all CRiSS parameters and MRI features of >8mm size and presence of necrosis or irregular outline were recorded, and patients were assigned CRiSS scores and groups.
Late metastasis of rectal adenocarcinoma to the penis.
BMJ Case Rep
November 2024
Urology, Royal Adelaide Hospital, Adelaide, South Australia, Australia.
Rectal cancer metastasising to the penis is an exceptionally rare clinical entity, with less than 80 reported cases. Metastasis to the penis is typically identified in conjunction with widespread metastatic disease and as such is usually associated with a very poor prognosis. We report a case of a man who presented with a metastatic deposit in his penis 15 years after the initial diagnosis of rectal cancer.
View Article and Find Full Text PDFA Rare Case of Malignant Melanoma of the Glans Penis in a Young Male Treated with an Organ-Preserving Surgical Procedure.
Cureus
October 2024
Urology, SRM Medical College Hospital and Research Centre, Chennai, IND.
Penile melanoma is a rare and highly invasive cancer that is generally diagnosed in the sixth to seventh decades of life. We report a rare case of primary malignant melanoma of the glans penis in a 38-year-old man who presented with a proliferative lesion over the glans with discoloration for six months. The clinical and metastatic workups were unremarkable.
View Article and Find Full Text PDFPenile Metastasis-Induced Priapism as the First Sign of Lung Cancer: A Case Report and Review of the Literature.
Case Rep Urol
November 2024
Urology Department, Cliniques universitaires Saint-Luc, Avenue Hippocrate 10 1200, Brussels, Belgium.
The penis is a relatively uncommon organ for metastases. Secondary lesions often originate from the bladder, prostate, or rectosigmoid cancers. Only a few cases have described penile lesions secondary to lung cancers, mostly as a later complication.
View Article and Find Full Text PDFTislelizumab plus chemotherapy in metastatic extramammary Paget disease after surgery: a case report.
Front Oncol
October 2024
Department of Urology, The 940t Hospital of Joint Logistics Support Force of Chinese People's Liberation Army, Lanzhou, Gansu, China.
Article Synopsis
- Extramammary Paget disease (EMPD) is a rare type of skin cancer that mainly affects areas with apocrine glands like the vulva, scrotum, and penis, and often has a poor prognosis, especially with distant metastases.
- Patients with localized EMPD generally have a good 5-year survival rate between 60%-92%, while those with metastases only have about a 10% survival rate.
- A case report highlights a 57-year-old man with metastatic EMPD who responded well to a combination of an immune checkpoint inhibitor and chemotherapy, suggesting this approach may improve outcomes for others with similar advanced disease.*
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!